NORTIC HOLDINGS INC has a total of 24 patent applications. It decreased the IP activity by 37.0%. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and medical technology are GORINSHTEYN BORIS, THERAMARK LIMITED and PELLEPHARM INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | Brazil | 1 | |
#6 | Canada | 1 | |
#7 | China | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Philippines | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Syringes |
# | Name | Total Patents |
---|---|---|
#1 | Kumar Amresh | 23 |
#2 | Sunthankar Prasanna | 23 |
#3 | Kavuru Vimal | 22 |
#4 | Kottayil S George | 19 |
#5 | Pati Kamalkishore | 9 |
#6 | Kottayil S | 3 |
#7 | Vimal Kavuru | 2 |
#8 | Kottayil George S | 1 |
#9 | Amresh Kumar | 1 |
#10 | Prasanna Sunthankar | 1 |
Publication | Filing date | Title |
---|---|---|
US2020397769A1 | Stable nimodipine parenteral formulation | |
US2020197338A1 | Therapeutic composition of intranasal lidocaine | |
US2020163947A1 | Methods of treatment using nimodipine parenteral formulations | |
US2019255033A1 | Stable Nimodipine Parenteral Formulation | |
WO2019006134A1 | Stable nimodipine parenteral formulation | |
KR20190005871A | Stable Nimodipine Parenteral Formulation | |
EP3405174A1 | Betamethasone oral spray formulation and method of use to treat ataxia |